HIVE Digital Amends Equity Distribution Agreement, Authorizing Up To $300M At-the-Market Share Offering; Up To $214.7M In Remaining Share Sales Under Prospectus Settlement
Hive Blockchain HIVE | 0.00 |
On June 16, 2026, HIVE Digital Technologies Ltd. a British Columbia corporation (the "Company" or "HIVE") amended and restated its existing Equity Distribution Agreement with Keefe, Bruyette & Woods, Inc., Cantor Fitzgerald & Co., Canaccord Genuity LLC, Roth Capital Partners LLC, B. Riley Securities, Inc., Northland Securities, Inc., and Rosenblatt Securities Inc. (the "U.S. Agents"), Stifel Nicolaus Canada Inc., Cantor Fitzgerald Canada Corporation, Canaccord Genuity Corp. and Roth Canada, Inc. (the "Canadian Agents" and, collectively together with the U.S. Agents, the "Agents") dated November 25, 2025 (such Equity Distribution Agreement, as amended and restated, is referred to herein as the "Equity Distribution Agreement"). Under the Equity Distribution Agreement, the Company may, from time to time at its option to or through any of the Agents, acting as agent and/or principal, offer and sell up to US$300,000,000 of shares of the Company's no par value common stock (the "Offering").
On June 17, 2026, the Company filed a prospectus supplement (the "Prospectus Supplement") with the Securities and Exchange Commission (the "SEC") as part of post-effective no. 1 on Form S-3ASR to the Company’s automatic shelf registration statement on Form F-3ASR (File No. 333-291676), originally filed with the SEC on November 20, 2025 (such registration statement, as amended, is referred to herein as the "Registration Statement"). Under the Prospectus Supplement, shares of the Company’s no par value common stock having an aggregate offering price of up to $214,696,023 may be sold, which reflects the unused portion of the previously authorized aggregate offering amount under the Equity Distribution Agreement as of the date of the Prospectus Supplement. The Prospectus Supplement supersedes and replaces, in its entirety, the Company’s prospectus supplement related to the Registration Statement and the Offering filed with the SEC on November 25, 2025.
